CLINICAL TRIALS PROFILE FOR XPOVIO
✉ Email this page to a colleague
All Clinical Trials for xpovio
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01607905 ↗ | Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer | Completed | Karyopharm Therapeutics Inc | Phase 1 | 2012-06-18 | Phase 1 study to evaluate the safety and tolerability of selinexor and determine the Recommended Phase 2 Dose (RP2D) of selinexor for advanced or metastatic solid tumor malignancies. |
NCT01607905 ↗ | Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer | Completed | Karyopharm Therapeutics, Inc | Phase 1 | 2012-06-18 | Phase 1 study to evaluate the safety and tolerability of selinexor and determine the Recommended Phase 2 Dose (RP2D) of selinexor for advanced or metastatic solid tumor malignancies. |
NCT02025985 ↗ | Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies | Completed | Karyopharm Therapeutics Inc | Phase 2 | 2014-04-09 | The primary trial objective is to determine the efficacy of KPT-330 (selinexor) in participants with advanced or metastatic gynaecological cancers by disease control rate (complete response (CR) or partial response (PR) or stable disease (SD) for at least 12 weeks, assessed according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. |
NCT02025985 ↗ | Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies | Completed | Karyopharm Therapeutics, Inc | Phase 2 | 2014-04-09 | The primary trial objective is to determine the efficacy of KPT-330 (selinexor) in participants with advanced or metastatic gynaecological cancers by disease control rate (complete response (CR) or partial response (PR) or stable disease (SD) for at least 12 weeks, assessed according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for xpovio
Condition Name
Clinical Trial Locations for xpovio
Trials by Country
Clinical Trial Progress for xpovio
Clinical Trial Phase
Clinical Trial Sponsors for xpovio
Sponsor Name